Videos

Daniel Drucker, MD, who coauthored the recent Endocrine Society scientific statement on obesity medicines, discusses key takeaways for primary care physicians.

Two on-label options are not enough for every patient. The panel weighs the field's remaining unmet needs against the biological rationale behind a newer, non-antipsychotic approach to treatment.

Decades of off-label prescribing for agitation associated with dementia due to Alzheimer’s are colliding with new evidence and new regulation. The panel examines why practice has lagged behind the data, and what is now changing.

Joshua LaBaer, PhD, reviews a national study he led that linked pre-existing antimicrobial antibodies with subsequent COVID-19 vaccine response.

Mina Fam, MD, addresses common prostate cancer misconceptions involving symptoms, elevated PSA, biopsy, and active surveillance.

Mina Fam, MD, reviews risk-based PSA interpretation, prostate MRI, biomarkers, and targeted biopsy in the modern diagnostic pathway.

Rodica Di Lorenzo, MD, explains why new headaches, migraine with aura, estrogen exposure, smoking, and pregnancy matter in stroke assessment.

A urologist discusses how primary care clinicians can identify patients most likely to benefit from prostate cancer screening while limiting overdiagnosis.

Before any prescription is written, non-pharmacologic strategies and a structured framework guide the panel's approach to agitation, alongside a biological explanation for why redirection so often fails.

Agitation does not stay contained to the patient. The panel examines the data linking agitation to caregiver burden, and the communication gaps that complicate coordinating care across specialties.

Brief speech, motor, vision, or balance changes may signal a TIA and require urgent evaluation, Rodica Di Lorenzo, MD, tells Patient Care Online.

Rodica Di Lorenzo, MD, of the Cleveland Clinic, reviews hypertension, lipids, diabetes, smoking, atrial fibrillation, and wearables in first-stroke prevention.

In "Improving Shared Decision-Making in Endometriosis Care," the panel opens Section 3 by asking why medical management still lags in everyday practice.

Experts weigh GLP-1 therapy's promise for PMOS against the risks of overly rapid weight loss in teenagers.

Experts break down which labs actually change PMOS management and how to avoid diagnostic pitfalls.

Distinguishing agitation from depression, anxiety, and psychosis shapes everything that follows in treatment. The panel walks through the clinical differences and where formal screening scales genuinely fit into daily practice.

Agitation eventually affects nearly every patient with Alzheimer's disease, yet it rarely looks like simple aggression. The panel outlines how common it is, the many forms it takes, and why it so often goes unrecognized.

Most patients meet PMOS in a primary care office first. Our experts map the referral threshold and argue insulin resistance — not just androgens — should drive how aggressively PCPs treat.

Our expert panel walks through the 2-criteria threshold for adolescents, the "at risk" category, and why untreated menstrual irregularity carries real long-term consequences.

In "Monitoring Safety and Symptom Relief During Endometriosis Therapy," Dr. Davitt details the practical monitoring plan he follows once a patient begins therapy.

Expert faculty demonstrate how thoughtful screening and careful interpretation can help primary care clinicians recognize hypercortisolism earlier and with greater confidence.

This episode, "Add-Back Therapy: Balancing Efficacy and Safety in Endometriosis," features Dr. Davitt reviewing 12-month efficacy and safety data on add-back therapy.

A global consensus just renamed PCOS to PMOS. Our experts explain why the shift moves care beyond the ovaries — and what it means for how clinicians talk to patients today.

In "Long-Term Data on Relugolix Combination Therapy for Endometriosis Pain," the panel reviews two-year outcomes from a major open-label extension trial.

Recognizing hypercortisolism is only the first step. Expert faculty discuss how thoughtful evaluation, strong clinical advocacy, and coordinated referral can help patients receive timely diagnosis and appropriate care.

In "Choosing Between Newer GnRH Antagonist Therapies for Endometriosis," Dr. Davitt compares two newer, FDA-approved options for treating endometriosis-associated pain.

Expert faculty examine how resistant hypertension may signal underlying hypercortisolism and discuss when clinicians should think beyond routine blood pressure management.

Once-weekly insulin's longer half-life reshapes the hypoglycemia conversation, and trial data point to a bigger role for CGM in primary care.

New research links cardiovascular-kidney-metabolic health stage to measurable arterial injury in adults as young as 23, with obesity the leading driver.

Josef Coresh, MD, discusses biomarkers, hearing correction, and integrated vascular care as emerging dementia prevention strategies.